|Articles|April 1, 2009

New Appraches to Diabetes Trials

Part 2 (14:14)

Part 2 (12:14)

Part 2 (9:19)

Part 2 (12:36)

Part 2 (11:17)

Part 2 (11:58)

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe

Related Content

How to Tell Substance from Branding in Biotech's Support Ecosystem

ByStella K. Vnook, PhD

August 10th 2026

ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma

ByAndy Studna, Senior Editor

August 10th 2026

FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership

ByAndy Studna, Senior Editor

August 7th 2026

What a Lean Development Model Actually Means for Biotech Operations Today

ByStella K. Vnook, PhD

August 7th 2026

ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap

ByAndy Studna, Senior Editor

August 7th 2026

New Appraches to Diabetes Trials

Related Content

How to Tell Substance from Branding in Biotech's Support Ecosystem

ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma

FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership

What a Lean Development Model Actually Means for Biotech Operations Today

ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap

Trending on Applied Clinical Trials Online

Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters

ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap

ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial

FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership

What a Lean Development Model Actually Means for Biotech Operations Today